Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, Philadelphia PA, Boston MA, Fairfax VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06106945
Phase 1, Phase 2, Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
for
Breast Cancer, Gastric Cancer, Esophageal Cancer,
Location: New York NY, Nashville TN, Dallas TX, Houston TX,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06695845
Phase 2, Recruiting
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
for
Androgen Axis Suppression, Prostatectomy, Prostate Cancer
Location: New York NY, Boston MA, Chicago IL, Kansas City KS,
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT06274047
Phase 3, Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
for
Narcolepsy
Location: Manhasset NY, Philadelphia PA, Danville PA, Boston MA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 0 - 17
Code: NCT04899947
Recruiting
Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation
for
Intestinal Transplantation
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18 - 65
Code: NCT04804891
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Morristown NJ, Albany NY, Bethesda MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase 3, Recruiting
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
for
Acute Myeloid Leukemia
Location: Stony Brook NY
Sponsor: Suhu Liu
Sex: All
Age: 18+
Code: NCT06297551
Recruiting
Performance of WOUNDCHEK Bacterial Status
for
Wound Heal
Location: Lake Success NY
Sponsor: Woundchek Laboratories BV
Sex: All
Age: 18+
Code: NCT06501105
Recruiting
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
for
Primary Immune Regulatory Disorder,
Location: New York NY, Philadelphia PA, Milwaukee WI, Atlanta GA,
Sponsor: Joseph Oved
Sex: All
Age: 0+
Code: NCT05787574
Phase 2, Recruiting
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Location: New York NY, Boston MA, Richmond VA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT03564340
Phase 1, Phase 2, Recruiting
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
for
Prostate Cancer
Location: New York NY, Harrison NY, Rockville Centre NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male
Age: 18+
Code: NCT06347705
Phase 2, Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
for
Crohn's Disease
Location: New York NY, Hartford CT, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 2 - 17
Code: NCT05509777
Phase 3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: New York NY, Belleville NJ, Shirley NY, Albany NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: New York NY, Shrewsbury NJ, New Bern NC, Charleston WV,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)